Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Stomatitis 1Neoplasms 1Lymphedema 1Disease 1

Interventions

Cyclophosphamide 517Bevacizumab 488Carboplatin 424pembrolizumab 388Paclitaxel 385Gemcitabine 372Cisplatin 366Docetaxel 323Rituximab 316Radiotherapy 296Nivolumab 247Doxorubicin 243Dexamethasone 240Fluorouracil 225Capecitabine 214Oxaliplatin 211Erlotinib Hydrochloride 206fludarabine phosphate 201Etoposide 188Cetuximab 186Lenalidomide 177Pemetrexed 176Bortezomib 174Trastuzumab 173Filgrastim 171fludarabine 166Prednisone 166Leucovorin 166Cytarabine 166Irinotecan 161

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Has results × Methylene Blue × Clear all
NCT03469284 2023-04-25

MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)

M.D. Anderson Cancer Center

Phase 2 Completed
69 enrolled 11 charts

Neoplasms, Stomatitis

NCT01276054 2014-08-01

Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.

University of Southern California

Phase 2 Terminated
4 enrolled 8 charts
Breast

Breast Neoplasms, Lymphedema

NCT00784849 2012-06-20

Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)

Louisiana State University Health Sciences Center in New Orleans

Phase 2 Completed
62 enrolled 5 charts
Breast

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡